DNA repair proteins and telomerase reverse transcriptase in the cochlear lateral wall of cisplatin-treated rats

Journal of Chemotherapy

Volumn 21, Issue 1, 2009, Pages 74-79

  Guthrie, O'Neil W ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cisplatin; Cochlear lateral wall; Nucleotide excision repair; Telomerase reverse transcriptase; Xeroderma pigmentosum

Indexed keywords

CISPLATIN; DNA; DNA REPAIR PROTEIN; NUCLEIC ACID BINDING PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP C PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA REPAIR; ENZYME ACTIVITY; EXCISION REPAIR; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; OTOTOXICITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; RAT; RECEPTOR UPREGULATION; UPREGULATION; XERODERMA PIGMENTOSUM;

EID: 63049124731     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2009.21.1.74     Document Type: Article

References (36)

1. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 2007; 226: 157-167.
2. van den Berg JH, Beijnen JH, Balm AJ, Schellens JH. Future opportunities in preventing cisplatin induced ototoxicity. Cancer Treat Rev., 32: 390-397, 2006.
3. Lippard, SJ. New chemistry of an old molecule: cis[(Pt(NH3)2C12]. Science 1982; 218: 1075-1082.
4. Valentine JS. The dioxygen ligand in mononuclear group VIII transition metal complexes. Chem. Rev 1973; 73: 235-245.
5. Buetter GR. In the absence of catalytic metals ascorbate does not autoxidize at pH 7: Ascorbate as a test for catalytic metals. J Biochem Biophys Methods 1988; 16: 27-40.
6. Khan MMT, Martell AE. Metal ion and metal chelate catalyzed oxidation of ascorbic acid by molecular oxygen I: Cupric and ferric ion catalyzed oxidation. J. Amer. Chem. Soc 1967; 89: 4176-4185.
7. Clerici WJ, Hensley K., DiMartino DL, Butterfield D A. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 1996; 98: 116-124.
8. Dehne N, Lautermann J, Petrat F, Rauen U, de Groot H. Cisplatin ototoxicity: Involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 2001; 174: 27-34.
9. Rybak LP, Husain K., Morris C, Whitworth C, Somani S. Effects of protective agents against cisplatin ototoxicity. Am J Otol 2000; 21: 513-520.
10. Ishibashi T, Lippard SJ. Telomere loss in cells treated with cisplatin. Proc. Natl. Acad. Sci. USA 1998; 95: 4219-4223.
11. Sun PM, Wei LH, Luo MY et al. The telomerase activity and expression of hTERT gene can serve as indicators in the anticancer treatment of human ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2007; 130: 249-257.
12. Reed E, Ozols RF, Tarone R, Yuspa SH, Poirier MC. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. Proc. Natl. Acad. Sci. USA 1987; 84: 5024-5028.
13. Fraval HN, Roberts JJ. Excision repair of cis-diamminedichloroplatinum(II)-induced damage to DNA of Chinese hamster cells. Cancer Res 1979; 39: 1793-1797.
14. Tapias A, Auriol J, Forget D et al. Ordered conformational changes in damaged DNA induced by nucleotide excision repair factors. J Bio Chem 2004; 279: 19074-19083.
15. Thoma BS, Vasquez KM. Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair. Mol Carcinog 2003; 38: 1-13.
16. Thomas JP, Lautermann J, Liedert B, Seiler F, Thomale J. High accumulation of platinum-DNA adducts in sinai marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity. Mol Pharmacol 2006; 70: 23-29.
17. van Ruijven MWM., de Groot JCMJ, Hendriksen F, Smoorenburg GF. Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs. Hear. Res 2005; 203: 112-121.
18. Minami SB, Sha S-H, Schacht J. Antioxidant protection in a new animal model of cisplatin-induced ototoxicity. Hear. Res 2004; 198: 137-143.
19. McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative for immunoelectron microscopy. J Histochem Cytochem 1974; 22: 1077-1083.
20. Wu Y-H, Cheng Y-W, Chang JT, Wu T-C, Chen C-Y, Lee H. Reduced XPC messaenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer. Cancer 2007; 110: 215-223.
21. Romanenko A, Morimura K, Wei M, Zaparin W, Vozianov A, Fukushima S. DNA damage repair in bladder urothelium after the Chemobyl accident in ukraine. d Urol 2002; 168: 973-977.
22. Jaitovich-Graisman I, Benlimame N, Slagle BL et al. Transcriptional regulation of the TFIIH transcription repair complexs XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue. J Biol Chem 2001; 276: 14124-14132.
23. Russo V, Berardinelli P, Martelli A et al. Expression of telomerase reverse transcriptase subunit (TERT) and telomere sizing in pig ovarian follicles. J Histochem Cytochem 2006; 54: 443-455.
24. Sparfel L, Langouet S, Fautrel A, Salles B, Guillouzo A. Investigations on the effects of oltipratz on the nucleotide excision repair in the liver. Biochem Pharmacol 2002; 63: 745-749.
25. Kasahara T, Kuwayama C, Hashiba M et al. The gene expression of hepatic proteins responsible for DNA repair and cell proliferation in tamoxifen-induced hepatocarcinogenesis. Cancer Sci 2003; 94: 582-588.
26. Coll M, Sherman SE, Gibson D. Lippard, SJ, Wang, AH: Molecular structure of the complex formed between the anti-cancer drug cisplatin and d(pGpG):C222(1) crystal form. J Biomol Struct Dyn 1990; 8: 315-330.
27. Fichtinger-Schepman AMJ, Vendnik CPJ, van Dijk-Knijnenburg WCM et al. Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or-resistant immunoglobulin m immunocytoma. Cancer Res 1989; 49: 2862-2867.
28. Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 1999; 99: 2467-2498.
29. Hey T, Lipps G, Sugasawa K, Iwai S, Hanaoka F, Krauss G. The XPC-HR23B complex displays high affinity and specificity for damaged DNA in a true-equilibrium fluorescence assay. Biochemistry 2002; 41: 6583-6587.
30. Janicijevic A, Sugasawa K, Shimizu Y et al. DNA bending by the human damage recognition complex XPC-HR23B. DNA Repair, 2: 325-336, 2003.
31. Conlee, JW, Gerity LC, Bennett, ML: Ongoing proliferation of melanocytes in the stria vascularis of adult guinea pigs. Hear Res 1994; 79: 115-122.
32. Roberson DW, Rubel EW: Cell division in the gerbil cochlea after acoustic trauma. Am J Otol 1994; 15: 28-34.
33. Lang H, Schulte BA, Schmiedt RA: Effect of chronic furosemide treatment and age on cell division in the adult gerbil inner ear. JARO 2003; 4: 164-175.
34. Dunaway G, Mhaskar Y, Armour G, Whitwonth C, Rybak L: Migration of cochlear lateral wall cells. Hear Res 2003; 177: 1-11.
35. Cardinaal RM, de Groot CMC, Huizing EH, Veldman JE, Smoorenburg GF. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea. Hear Res 2000; 144: 135-146.
36. Sluyter S, Klis SFL, de Groot JCM.J, Smoorenburgh GF. Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery. Hear Res 2003; 185: 49-56.